Biotech raises in Boston

19 biotech companies in Boston filed in the last 90 days, against 14 in the 90 days before. The biggest raise on record here is Galecto, Inc. at $285M.

Companies raising per week

The last 90 days

Copy the list as CSV

First-time filers, last 90 days

AdvanCell, Inc., FluidForm Bio, Inc., Simplicia, Inc., Headlands Holdco, LLC, Platform Therapeutics, Inc., Sailie Bio, Inc., Typewriter Therapeutics, Inc..

Everything on record

Other sectors in Boston

AI and software Pharmaceuticals Energy and climate Manufacturing Health care Retail and restaurants

Biotech in other metros

New York San Diego Detroit San Francisco Bay Area Miami Denver and Boulder Philadelphia Seattle Washington, DC Austin Houston Orlando and Tampa Baltimore Los Angeles Raleigh-Durham Northern New Jersey Salt Lake City Dallas-Fort Worth Chicago Minneapolis-St. Paul Pittsburgh

How this list is built

Every company here filed a Form D with the SEC from this sector and metro. A Form D is the notice a company files when it sells shares or other securities without a public offering, so it catches seed rounds, small rounds and rounds that were never announced, alongside the large ones that make the news. Only new offerings by operating companies count: amendments, pooled investment funds, real estate vehicles and special purpose vehicles are left out, so each row is a company raising money for itself.

The amount shown is the total the filing reports as sold so far. Some filings report nothing sold yet; those rows show a dash and add nothing to the totals. "First filing" marks a company whose first Form D on record this is. Each company links to our page for the filing, or to the SEC's own copy, and the list can be copied as CSV for a spreadsheet.